Allan Sylvest Aasberg CFO

Roles

EQL Pharma AB Stockholm
CFO
14.08.202614.08.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
14.08.2026EQL Pharma AB Stockholm
Bought — open marketAcquisition
20,000SEK 26.36
SEK 527,200.00